AADR vs BBP

Both AADR and BBP are ETFs. AADR has a lower 5-year return than BBP (0.72% vs 3.41%). AADR has a higher expense ratio than BBP (1.1% vs 0.79%). Below is the comparison between AADR and BBP.

AADR BBP
Segment Equity: Global Ex-U.S. - Total Market Growth Equity: U.S. Biotech
Issuer AdvisorShares Virtus
Net Assets $62.45M $21.57M
Expense Ratio 1.10% 0.79%
Management Style passive (index-based) passive (index-based)
Dividend Yield 0.77% 0.00%
Underlying Index -- LifeSci Biotechnology Products Index
YTD Return -27.58% -15.85%
1-Year Return -14.75% -19.74%
3-Year Return -5.15% -0.43%
5-Year Return 0.72% 3.41%
10-Year Return N/A N/A

AADR description

The Fund seeks long-term capital appreciation above international benchmarks such as the MSCI EAFE Index and the BNY Mellon Classic ADR Index. The Fund selects a portfolio of U.S. traded securities of non-U.S. organizations, most often American Depositary Receipts (ADRs), included in the BNY Mellon Classic ADR Index.

AADR returns

YTD Return -27.58%
1-Month Return -23.10%
3-Month Return -28.48%
1-Year Return -14.75%
3-Year Return -5.15%
5-Year Return 0.72%
10-Year Return N/A
AADR expense ratio is 1.1%.

AADR holdings

Top 10 Holdings (38.23% of Total Assets)

Name Symbol % Assets
Galapagos NV ADR GLPG 5.47%
NICE Ltd ADR NICE 5.06%
MercadoLibre Inc MELI.SA 3.94%
argenx SE ADR ARGX 3.79%
Cosan Ltd CZZ.SA 3.64%
WNS (Holdings) Ltd ADR WNS 3.48%
Gold Fields Ltd ADR GFI.JO 3.43%
Allegion PLC ALLE 3.26%
TAL Education Group ADR TAL 3.2%
Anglogold Ashanti Ltd ADR AU.JO 2.96%

BBP description

The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the BioShares Biotechnology Products Index. The Index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering or product candidate.

BBP returns

YTD Return -15.85%
1-Month Return -14.16%
3-Month Return -14.24%
1-Year Return -19.74%
3-Year Return -0.43%
5-Year Return 3.41%
10-Year Return N/A
BBP expense ratio is 0.79%.

BBP holdings

Top 10 Holdings (29.66% of Total Assets)

Name Symbol % Assets
Acceleron Pharma Inc XLRN 4.02%
Momenta Pharmaceuticals Inc MNTA 3.99%
Ultragenyx Pharmaceutical Inc RARE 3.1%
Regeneron Pharmaceuticals Inc REGN 2.79%
United Therapeutics Corp UTHR 2.71%
PTC Therapeutics Inc PTCT 2.68%
Biomarin Pharmaceutical Inc BMRN 2.66%
Theravance Biopharma Inc TBPH 2.63%
Retrophin Inc RTRX 2.55%
Insmed Inc INSM 2.53%
Follow Us